fladrafinil
chemical compound
≈ 1 min read
Names in other languages
- Français2-[bis(4-fluorophényl)méthylsulfinyl]-N-hydroxyacétamide
- DeutschFladrafinil
- Englishfladrafinil
- shCRL-40,941
- СрпскиCRL-40,941
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Fladrafinil (developmental code name CRL-40,941), also known as fluorafinil or as bisfluoroadrafinil, is a wakefulness-promoting agent related to modafinil that was never marketed. It is sold online and used non-medically as a nootropic (cognitive enhancer).
Modafinil and its analogues are known to act as dopamine reuptake inhibitors and this is thought to be involved in their wakefulness-promoting effects. Chemically, fladrafinil is a derivative of adrafinil (N-hydroxymodafinil) and is also known as bisfluoroadrafinil (it is the bis(4-fluoro) phenyl ring-substituted derivative of adrafinil).
It is closely related to flmodafinil (CRL-40,940; bisfluoromodafinil).
Pharmacodynamics
Fladrafinil has been found to produce antiaggressive effects in animals, which adrafinil does not produce. Fladrafinil is purportedly 3 to 4 times more potent than adrafinil in this action.
Analogues
Analogues of fladrafinil include modafinil, armodafinil ((R)-modafinil), esmodafinil ((S)-modafinil), adrafinil (CRL-40,028; N-hydroxymodafinil), flmodafinil (CRL-40,940; bisfluoromodafinil), and CE-123, among others.
History
Fladrafinil appears to have first been patented in the 1980s.
Research
The pharmacokinetics of fladrafinil are being studied.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1373181536 under CC BY-SA 4.0; modifications have been made.